Literature DB >> 17134965

Gene expression regulation and cancer.

M Dolore Delgado1, Javier León.   

Abstract

Gene expression is mostly controlled at the level of the transcription initiation. The transcription control regions of protein-encoding genes include: the core promoter, where RNA polymerase II binds, the proximal and distal promoter, responsible for gene expression regulation, and the enhancers and silencers. Chromatin represents an additional level of regulation of gene expression. The switching between inactive and active chromatin is closely related to the activity of histone-modifying enzymes and chromatin-remodelling complexes. Transcriptional activation of a gene requires the binding of specific transcription factors to regulatory DNA elements, the opening of the chromatin, the binding of Mediator, and the assembly of the preinitiation complex with RNA polymerase and RNA synthesis initiation. Transcription factors ultimately transduce the proliferation signals elicited by growth factors. Moreover, many human oncogenes encode for transcription factors, and some of them are prevalent in particular neoplasias (e.g., MYC, MLL, PML-RARa). Also, some of the most prominent tumor suppressors (e.g. p53) are transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17134965     DOI: 10.1007/s12094-006-0132-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  36 in total

Review 1.  The nucleosome: from genomic organization to genomic regulation.

Authors:  Sepideh Khorasanizadeh
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  RNA polymerase II structure, and organization of the preinitiation complex.

Authors:  Francisco J Asturias
Journal:  Curr Opin Struct Biol       Date:  2004-04       Impact factor: 6.809

Review 3.  Mediator and the mechanism of transcriptional activation.

Authors:  Roger D Kornberg
Journal:  Trends Biochem Sci       Date:  2005-05       Impact factor: 13.807

Review 4.  The dynamics of chromatin remodeling at promoters.

Authors:  Jane Mellor
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

Review 5.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 6.  Non-coding-RNA regulators of RNA polymerase II transcription.

Authors:  James A Goodrich; Jennifer F Kugel
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05-24       Impact factor: 94.444

Review 7.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

Review 8.  Molecular biology in acute leukemia.

Authors:  Mireia Camós; Dolors Colomer
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

Review 9.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

Review 10.  The P53 pathway: what questions remain to be explored?

Authors:  A J Levine; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

View more
  9 in total

1.  PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Authors:  Shilpa Nadimpalli Kobren; Bernard Chazelle; Mona Singh
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

2.  TGF-beta1 modulates focal adhesion kinase expression in rat intestinal epithelial IEC-6 cells via stimulatory and inhibitory Smad binding elements.

Authors:  Mary F Walsh; Dinakar R Ampasala; Arun K Rishi; Marc D Basson
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 3.  Regulation and misregulation of Eph/ephrin expression.

Authors:  Dina N Arvanitis; Alice Davy
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

4.  BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer.

Authors:  Shirin Shahbazi; Sara Alavi; Keivan Majidzadeh-A; Massoud Ghaffarpour; Azam Soleimani; Reza Mahdian
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

5.  Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus.

Authors:  Yu Zheng; Weidong Fan; Xianquan Zhang; Erbo Dong
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

6.  DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.

Authors:  Manabu Fuchikami; Shigeru Morinobu; Masahiro Segawa; Yasumasa Okamoto; Shigeto Yamawaki; Norio Ozaki; Takeshi Inoue; Ichiro Kusumi; Tsukasa Koyama; Kounosuke Tsuchiyama; Takeshi Terao
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

Review 7.  Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

8.  Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma.

Authors:  Nazila Nouraee; Katrien Van Roosbroeck; Mohammad Vasei; Shahriar Semnani; Nader Mansour Samaei; Farshad Naghshvar; Abbas Ali Omidi; George A Calin; Seyed Javad Mowla
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression.

Authors:  Yixuan Song; Koichi Miyaki; Tomoko Suzuki; Yasuharu Sasaki; Akizumi Tsutsumi; Norito Kawakami; Akihito Shimazu; Masaya Takahashi; Akiomi Inoue; Chiemi Kan; Sumiko Kurioka; Takuro Shimbo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-05-07       Impact factor: 3.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.